These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 33667953)

  • 1. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.
    Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD
    Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
    Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
    Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated intravenous infusion of mesenchymal stem cells enhances recovery of motor function in a rat model with chronic spinal cord injury.
    Kurihara K; Sasaki M; Nagahama H; Obara H; Fukushi R; Hirota R; Yoshimoto M; Teramoto A; Kocsis JD; Yamashita T; Honmou O
    Brain Res; 2023 Oct; 1817():148484. PubMed ID: 37442249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study.
    Larocca TF; Macêdo CT; Souza BSF; Andrade-Souza YM; Villarreal CF; Matos AC; Silva DN; da Silva KN; de Souza CLEM; Paixão DDS; Bezerra MDR; Alves RL; Soares MBP; Dos Santos RR
    Cytotherapy; 2017 Oct; 19(10):1189-1196. PubMed ID: 28760352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and potential effects of intrathecal injection of allogeneic human umbilical cord mesenchymal stem cell-derived exosomes in complete subacute spinal cord injury: a first-in-human, single-arm, open-label, phase I clinical trial.
    Akhlaghpasand M; Tavanaei R; Hosseinpoor M; Yazdani KO; Soleimani A; Zoshk MY; Soleimani M; Chamanara M; Ghorbani M; Deylami M; Zali A; Heidari R; Oraee-Yazdani S
    Stem Cell Res Ther; 2024 Aug; 15(1):264. PubMed ID: 39183334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.
    Syková E; Jendelová P; Urdzíková L; Lesný P; Hejcl A
    Cell Mol Neurobiol; 2006; 26(7-8):1113-29. PubMed ID: 16633897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.
    Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A
    Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.
    Albu S; Kumru H; Coll R; Vives J; Vallés M; Benito-Penalva J; Rodríguez L; Codinach M; Hernández J; Navarro X; Vidal J
    Cytotherapy; 2021 Feb; 23(2):146-156. PubMed ID: 32981857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury.
    Bydon M; Dietz AB; Goncalves S; Moinuddin FM; Alvi MA; Goyal A; Yolcu Y; Hunt CL; Garlanger KL; Del Fabro AS; Reeves RK; Terzic A; Windebank AJ; Qu W
    Mayo Clin Proc; 2020 Feb; 95(2):406-414. PubMed ID: 31785831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial.
    Zamani H; Soufizomorrod M; Oraee-Yazdani S; Naviafar D; Akhlaghpasand M; Seddighi A; Soleimani M
    Spinal Cord; 2022 Jan; 60(1):63-70. PubMed ID: 34504283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial.
    Oka S; Yamaki T; Sasaki M; Ukai R; Takemura M; Yokoyama T; Kataoka-Sasaki Y; Onodera R; Ito YM; Kobayashi S; Kocsis JD; Iwadate Y; Honmou O
    JMIR Res Protoc; 2022 Jul; 11(7):e37898. PubMed ID: 35793128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
    Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
    Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of mesenchymal stem cells and scaffolds promotes motor functional recovery in spinal cord injury: a systematic review and meta-analysis.
    Yousefifard M; Nasseri Maleki S; Askarian-Amiri S; Vaccaro AR; Chapman JR; Fehlings MG; Hosseini M; Rahimi-Movaghar V
    J Neurosurg Spine; 2020 Feb; 32(2):269-284. PubMed ID: 31675724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase III Clinical Trial Showing Limited Efficacy of Autologous Mesenchymal Stem Cell Therapy for Spinal Cord Injury.
    Oh SK; Choi KH; Yoo JY; Kim DY; Kim SJ; Jeon SR
    Neurosurgery; 2016 Mar; 78(3):436-47; discussion 447. PubMed ID: 26891377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells.
    Xiao Z; Tang F; Zhao Y; Han G; Yin N; Li X; Chen B; Han S; Jiang X; Yun C; Zhao C; Cheng S; Zhang S; Dai J
    Cell Transplant; 2018 Jun; 27(6):907-915. PubMed ID: 29871514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial.
    Hur JW; Cho TH; Park DH; Lee JB; Park JY; Chung YG
    J Spinal Cord Med; 2016 Nov; 39(6):655-664. PubMed ID: 26208177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans.
    Park JH; Kim DY; Sung IY; Choi GH; Jeon MH; Kim KK; Jeon SR
    Neurosurgery; 2012 May; 70(5):1238-47; discussion 1247. PubMed ID: 22127044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.
    Osaka M; Honmou O; Murakami T; Nonaka T; Houkin K; Hamada H; Kocsis JD
    Brain Res; 2010 Jul; 1343():226-35. PubMed ID: 20470759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study.
    Satti HS; Waheed A; Ahmed P; Ahmed K; Akram Z; Aziz T; Satti TM; Shahbaz N; Khan MA; Malik SA
    Cytotherapy; 2016 Apr; 18(4):518-22. PubMed ID: 26971680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.